Target intelligence / Profile preview

Copper (ion) (Cu)

Target
Cu
Molecular classification
Metal ion, Trace element, Enzyme cofactor
01

Overview

Copper is an essential trace element that serves as a critical cofactor for numerous enzymes involved in cellular respiration, antioxidant defense, and iron metabolism (NIH, 2024). Under normal physiological conditions, copper levels are tightly regulated by transporters such as ATP7B, which facilitates its excretion into the bile (UniProt, 2024). 'Copper overload' or 'copper-induced pathology' occurs when these homeostatic mechanisms fail, leading to the toxic accumulation of copper ions in tissues, particularly the liver and brain (PubMed, 2023). This accumulation triggers the production of reactive oxygen species, resulting in oxidative stress, lipid peroxidation, and mitochondrial damage (NIH, 2024). Clinically, this is most prominent in Wilson disease, an autosomal recessive disorder characterized by hepatic cirrhosis and neuropsychiatric symptoms (StatPearls, 2024). Therapeutic intervention primarily targets the copper ion itself through the use of chelating agents like D-penicillamine and trientine, which sequester the metal for renal excretion (PubChem, 2024). Additionally, zinc salts are used to induce metallothionein in the gut, which traps dietary copper and prevents its absorption (NIH, 2024). Effective management of copper levels is essential to halt disease progression and mitigate the severe organ damage associated with chronic copper toxicity.

Other names
Cu2+Cu+Cupric ionCuprous ionCopper cationCopper toxicityCopper overloadCopper-induced pathology
02

Mechanism of action

Chelation and sequestration of copper ions to facilitate renal excretion; induction of intestinal metallothionein to block absorption.

03

Biological functions

Mitochondrial respirationAntioxidant defenseIron homeostasisNeurotransmitter synthesisConnective tissue formationCell signaling
04

Disease associations

Wilson diseaseMenkes diseaseAlzheimer's diseaseCancerLiver cirrhosisHepatitis
05

Safety considerations

NephrotoxicityBone marrow suppressionNeurological worsening upon treatment initiationCopper deficiencyTeratogenicityHypersensitivity reactions
06

Interacting drugs

D-penicillamine

5 more in the full profile.

07

Biomarkers

Serum ceruloplasmin24-hour urinary copperNon-ceruloplasmin bound copperLiver copper concentrationKayser-Fleischer rings

Beyond the preview

Go deeper on Copper (ion) (Cu).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper (ion) (Cu).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call